We are live on
!
Find out more
TCM
Traynor Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
62.36%
This Fund
S&P 500
This Quarter
Est. Return
+1.18%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$120M
AUM Growth
+$15.6M
(+15%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
13.04%
Top 10 Holdings %
Top 10 Hldgs %
46.75%
Holding
154
New
30
Increased
62
Reduced
44
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$2.65M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$895K |
| 3 |
PGP
PIMCO Global StockPLUS & Income Fund
PGP
|
+$827K |
| 4 |
Biogen
BIIB
|
+$795K |
| 5 |
Pfizer
PFE
|
+$666K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$605K |
| 2 |
Manitowoc
MTW
|
+$406K |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$398K |
| 4 |
Advanced Micro Devices
AMD
|
+$346K |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.26% |
| 2 | Technology | 12.31% |
| 3 | Communication Services | 5.77% |
| 4 | Industrials | 3.81% |
| 5 | Energy | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
76
PPL Corp
PPL
$26.3B
| $350K | 0.29% |
11,880
-499
| -4% | -$15.6K |
|
|
SUNE
77
DELISTED
SUNEDISON, INC COM
SUNE
| $348K | 0.29% |
11,658
+2,275
| +24% | +$64.8K |
|
78
Baidu
BIDU
$38.5B
| $346K | 0.29% |
+1,740
| New | +$356K |
|
|
BCS.PRA.CL
79
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
| $344K | 0.29% |
13,263
-1,065
| -7% | -$27.6K |
|
80
Icon
ICLR
$12.7B
| $334K | 0.28% |
4,970
+560
| +13% | +$37.8K |
|
81
PepsiCo
PEP
$190B
| $329K | 0.27% |
+3,535
| New | +$338K |
|
82
Illumina
ILMN
$30.5B
| $327K | 0.27% |
+1,540
| New | +$301K |
|
|
RUSL
83
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
| $313K | 0.26% |
6,452
+700
| +12% | +$41.7K |
|
84
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.03B
| $311K | 0.26% |
+961
| New | +$422K |
|
85
Southwest Airlines
LUV
$24B
| $306K | 0.26% |
9,252
+1,353
| +17% | +$52.9K |
|
86
Prothena Corp
PRTA
$447M
| $306K | 0.26% |
+5,828
| New | +$230K |
|
87
Constellation Brands
STZ
$22.4B
| $302K | 0.25% |
2,610
+765
| +41% | +$90.3K |
|
88
Chevron
CVX
$377B
| $301K | 0.25% |
+3,120
| New | +$328K |
|
|
GTLS
89
DELISTED
Chart Industries
GTLS
| $298K | 0.25% |
8,354
+2,300
| +38% | +$84.2K |
|
90
Textron
TXT
$15.3B
| $290K | 0.24% |
6,510
-224
| -3% | -$10.2K |
|
91
Cigna
CI
$71.6B
| $288K | 0.24% |
1,780
-1,000
| -36% | -$138K |
|
92
Huntington Bancshares
HBAN
$35.7B
| $286K | 0.24% |
25,329
-2,235
| -8% | -$25K |
|
93
iShares Core S&P 500 ETF
IVV
$906B
| $286K | 0.24% |
1,382
-30
| -2% | -$6.35K |
|
94
JetBlue
JBLU
$2.43B
| $284K | 0.24% |
13,700
+1,400
| +11% | +$28.4K |
|
95
BioMarin Pharmaceuticals
BMRN
$11.8B
| $281K | 0.23% |
2,055
| – | – |
|
96
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.1B
| $280K | 0.23% |
6,620
-488
| -7% | -$20.9K |
|
97
AT&T
T
$159B
| $276K | 0.23% |
10,294
+17
| +0.2% | +$439 |
|
|
SCHW
98
Charles Schwab
SCHW
$187B
| $271K | 0.23% |
+8,317
| New | +$263K |
|
99
iShares Core 10+ Year USD Bond ETF
ILTB
$597M
| $269K | 0.22% |
4,561
-2,238
| -33% | -$138K |
|
|
AFFX
100
DELISTED
Affymetrix Inc
AFFX
| $268K | 0.22% |
24,550
+200
| +0.8% | +$2.42K |
|
Similar funds
SIG
ICM
CAG
ET
MMLI
MIAS
ORCP
TAL
Traynor Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Traynor Capital Management held 154 positions worth $120M, up 15% from $104M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Traynor Capital Management deployed $15.6M of net new capital in Q2 2015, opening 30 new positions and adding to 62 existing holdings. Its largest new stake was Biogen: 1,980 shares worth $799K.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $398K trimmed.
- Traynor Capital Management's largest Q2 2015 buy was Biogen: 1,980 shares worth $799K.
- Traynor Capital Management added most to Novo Nordisk in Q2 2015, an estimated $2.65M increase.
- Traynor Capital Management's biggest Q2 2015 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $398K.
- Traynor Capital Management fully exited Eli Lilly in Q2 2015, selling an estimated $605K.
- Traynor Capital Management's ten largest holdings make up 47% of its $120M portfolio in Q2 2015.
- Traynor Capital Management opened 30 new positions and closed 13 in Q2 2015.
- Traynor Capital Management's portfolio value rose 15% quarter-over-quarter to $120M.
Based on Traynor Capital Management's 13F filing for Q2 2015, filed 23 Feb 2016.